Clinitech Laboratory Complete Financial Statements

In FYNone, Clinitech Laboratory (CTLLAB) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00. Full financial statements from FY2021 to FY2025 (5 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Clinitech Laboratory share price chart.

5 Years of Data
2025 - 2021

Complete Financial Data Export

Profitability Ratios

EBITDA Margin 11.11% 2025 data
Operating Margin 10.00% 2025 data

Balance Sheet Ratios

Equity Ratio 81.82% 2025 data
Asset Turnover 0.82 2025 data

CTLLAB Revenue, Net Profit & EBITDA — Year-on-Year Growth

CTLLAB YoY (March 2025 vs Period) — revenue -100.0%, EBITDA -100.0%, expenses -100.0%.

Revenue Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+83.3%
Year-over-Year
Equity Growth
+125.0%
Year-over-Year
Investing Cash Flow Growth
-200.0%
Year-over-Year

CTLLAB Income Statement — Revenue, EBITDA & Net Profit

Clinitech Laboratory revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None). Explore CTLLAB Benjamin Graham valuation to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023 March 2022 March 2021
Revenue 0 9 6 6 7 5
Expenses 0 7 5 5 5 4
EBITDA 0 1 1 1 1 1
Operating Profit Margin % 0.00% 10.00% 16.00% 21.00% 17.00% 18.00%
Depreciation 0 0 0 0 0 0
Interest 0 0 0 0 0 0
Profit Before Tax 0 1 1 1 1 1
Tax 0 0 0 0 0 0
Net Profit 0 0 0 1 1 0
Earnings Per Share (₹) 0.00 1.90 2.37 4.09 3.42 6.04

CTLLAB Balance Sheet — Assets, Liabilities & Shareholders' Equity

CTLLAB total assets ₹11 Cr, total equity ₹9 Cr, total liabilities ₹ Cr (2025).

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021
ASSETS
Total Assets 11 6 6 4 3
Current Assets 7 3 2 1 2
Fixed Assets 2 2 1 2 1
Capital Work in Progress 1 1 1 0 0
Investments 0 0 0 0 0
Other Assets 8 3 4 2 2
LIABILITIES
Total Liabilities
Current Liabilities 0 0 2 1 1
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 9 4 2 2 1
Share Capital 2 2 2 2 1
Reserves & Surplus 7 2 1 0 1

CTLLAB Cash Flow Statement — Operating, Investing & Financing

Clinitech Laboratory operating cash flow ₹-1 Cr, investing ₹-1 Cr, financing ₹4 Cr, net cash flow ₹2 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021
Operating Activities -1 -1 1 1 0
Investing Activities -1 1 -1 -2 1
Financing Activities 4 0 0 0 -1
Net Cash Flow 2 0 1 0 0